• About us
    • Profile
    • Management
    • Board
    • Scientific Advisory Board
  • Our Science
    • Strategy
    • Enabling Technologies
    • Product Classes
    • Publications
  • Pipeline
    • Pipeline
    • NidlegyTM
    • Fibromun
    • Darleukin
    • Dodekin
    • Dekavil
    • OncoFAP Radio Conjugates (Imaging)
    • OncoFAP Radio Conjugates (Therapy)
    • OncoFAP-GlyPro-MMAE (Therapy)
    • OncoACP3 (Imaging)
    • OncoACP3 (Therapy)
    • OncoCAIX
  • Press Releases & Media
    • Press Releases
    • Events
    • Media Library
    • Philogen in the news
  • Work with us
    • Careers
    • Partnering
  • Investors
    • Investor Relations
    • Shareholding
    • IPO
    • Press Releases
    • Financial Statements
    • Financial Calendar
    • Internal Dealing
    • Buyback
    • Analyst Coverage
    • Webinars
    • IR Contacts
  • Governance
    • Board of Directors
    • Board of Statutory Auditors
    • Documents & Procedures
    • Shareholders’ Meetings
    • Codice etico e Modello 231
    • Sustainability (ESG)
Governance
Investors
  • About us
    • Profile
    • Management
    • Board
    • Scientific Advisory Board
  • Our Science
    • Strategy
    • Enabling Technologies
    • Product Classes
    • Publications
  • Pipeline
    • Pipeline
    • NidlegyTM
    • Fibromun
    • Darleukin
    • Dodekin
    • Dekavil
    • OncoFAP Radio Conjugates (Imaging)
    • OncoFAP Radio Conjugates (Therapy)
    • OncoFAP-GlyPro-MMAE (Therapy)
    • OncoACP3 (Imaging)
    • OncoACP3 (Therapy)
    • OncoCAIX
  • Press Releases & Media
    • Press Releases
    • Events
    • Philogen in the news
    • Media Library
  • Work with us
    • Careers
    • Partnering

Philogen to attend the 12th International Congress on Encoded Combinatorial Libraries in Shanghai (China) on October 12, 2024

Mar 22, 2025 | 2024, Past Events, Scientific

Prof. Dario Neri gave the Opening Lecture entitled: “DNA-encoded chemical libraries: past, present and future”  

Philogen to attend the VIII Siena Think Tank in Siena (Italy) on October 4, 2024

Mar 22, 2025 | 2024, Past Events

Philogen to attend the VIII Siena Think Tank in Siena (Italy) on October 4, 2024

Philogen to attend the Group Retreat of the group of Prof. Dr. Markus Manz in Bergün (Switzerland) on September 9, 2024

Mar 22, 2025 | 2024, Past Events, Scientific

Prof. Dario Neri gave a presentation on  “Tumor targeting”  

Philogen to attend the International Controlled Release Congress in Bologna (Italy) on July 9, 2024

Mar 22, 2025 | 2024, Past Events, Scientific

Prof. Dario Neri gave a duet lecture entitled: “Nanomedicines, antibodies and imaging for cancer therapy”  

Philogen to attend the Institute for Chemical Immunology Conference 2024 in Leiden (The Netherlands) on June 28, 2024

Mar 22, 2025 | 2024, Past Events, Scientific

Prof. Dario Neri gave a presentation entitled: “From encoded combinatorial libraries to clinical-stage targeted therapeutics”

Philogen to attend the Novo Nordisk Foundation Symposium on Chemical Biology: from Molecules to Medicine in Copenhagen (Denmark) on June 7, 2024

Mar 22, 2025 | 2024, Past Events

Prof. Dario Neri gave a presentation entitled: “From encoded combinatorial libraries to clinical-stage targeted therapeutics”
« Older Entries
Next Entries »

Recent Posts

  • Deposito del Verbale dell’Assemblea degli Azionisti
  • Il Consiglio di Amministrazione approva la posizione finanziaria netta relativa al Primo Trimestre 2026
  • The Board of Directors approves the financial position for the first quarter of 2026 (Courtesy English Translation)
  • Philogen to attend the 74th American Society Mass Spectrometry annual conference in San Diego, May 31 – June 4 2026
  • Philogen to attend the Society of Nuclear Medicine and Molecular Imaging (SNMM) annual meeting on May 30 – June 2, 2026

Recent Comments

    Legal

    Privacy Policy

    Privacy Policy / Cookie Policy

      Contacts

    • Follow
    • Follow

    Philogen S.p.A. ©  Piazza La Lizza, 7 | 53100 Siena (SI) – ITALY | Nr. REA: SI-98772 | P.IVA e CF 00893990523 | Cap. Soc. € 5.731.226,64 i.v. | PEC: AFC@pec.philogengroup.it